Since an association between myocardial infarction (MI) and respiratory infections has been described for influenza viruses and other respiratory viral agents, understanding possible physiopathological links between severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and acute coronary syndromes (ACS) is of the greatest importance. The initial data suggest an underestimation of ACS cases all over the world, but acute MI still represents a major cause of morbidity and mortality worldwide and should not be overshadowed during the coronavirus disease (Covid-19) pandemic. No common consensus regarding the most adequate healthcare management policy for ACS is currently available. Indeed, important differences have been reported between the measures employed to treat ACS in China during the first disease outbreak and what currently represents clinical practice across Europe and the USA. This review aims to discuss the pathophysiological links between MI, respiratory infections, and Covid-19; epidemiological data related to ACS at the time of the Covid-19 pandemic; and learnings that have emerged so far from several catheterization labs and coronary care units all over the world, in order to shed some light on the current strategies for optimal management of ACS patients with confirmed or suspected SARS-CoV-2 infection.

Acute Coronary Syndromes and Covid-19 : Exploring the Uncertainties / M. Schiavone, C. Gobbi, B. Giuseppe, F. D’Ascenzo, A. Palazzuoli, A. Gasperetti, G. Mitacchione, M. Viecca, M. Galli, F. Fedele, M. Mancone, G. Battista Forleo. - In: JOURNAL OF CLINICAL MEDICINE. - ISSN 2077-0383. - 9:6(2020 Jun 02), pp. 1683.1-1683.19.

Acute Coronary Syndromes and Covid-19 : Exploring the Uncertainties

M. Schiavone;C. Gobbi;B. Giuseppe;A. Gasperetti;M. Galli;
2020

Abstract

Since an association between myocardial infarction (MI) and respiratory infections has been described for influenza viruses and other respiratory viral agents, understanding possible physiopathological links between severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and acute coronary syndromes (ACS) is of the greatest importance. The initial data suggest an underestimation of ACS cases all over the world, but acute MI still represents a major cause of morbidity and mortality worldwide and should not be overshadowed during the coronavirus disease (Covid-19) pandemic. No common consensus regarding the most adequate healthcare management policy for ACS is currently available. Indeed, important differences have been reported between the measures employed to treat ACS in China during the first disease outbreak and what currently represents clinical practice across Europe and the USA. This review aims to discuss the pathophysiological links between MI, respiratory infections, and Covid-19; epidemiological data related to ACS at the time of the Covid-19 pandemic; and learnings that have emerged so far from several catheterization labs and coronary care units all over the world, in order to shed some light on the current strategies for optimal management of ACS patients with confirmed or suspected SARS-CoV-2 infection.
acute coronary syndromes; myocardial infarction; STEMI; Covid-19; infectious disease; respiratoryinfections; pathophysiology; percutaneous coronaryintervention; thrombolysis; drugtreatment
Settore MED/17 - Malattie Infettive
2-giu-2020
Article (author)
File in questo prodotto:
File Dimensione Formato  
jcm-09-01683.pdf

accesso aperto

Tipologia: Publisher's version/PDF
Dimensione 696.78 kB
Formato Adobe PDF
696.78 kB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/773351
Citazioni
  • ???jsp.display-item.citation.pmc??? 49
  • Scopus 77
  • ???jsp.display-item.citation.isi??? 63
social impact